Adjustment for time-invariant and time-varying confounders in 'unexplained residuals' models for longitudinal data within a causal framework and associated challenges.

Unexplained residuals model causal inference conditional analysis conditional growth conditional regression model conditional size conditional weight directed acyclic graph lifecourse epidemiology

Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 17 2 2018
medline: 25 7 2020
entrez: 17 2 2018
Statut: ppublish

Résumé

'Unexplained residuals' models have been used within lifecourse epidemiology to model an exposure measured longitudinally at several time points in relation to a distal outcome. It has been claimed that these models have several advantages, including: the ability to estimate multiple total causal effects in a single model, and additional insight into the effect on the outcome of greater-than-expected increases in the exposure compared to traditional regression methods. We evaluate these properties and prove mathematically how adjustment for confounding variables must be made within this modelling framework. Importantly, we explicitly place unexplained residual models in a causal framework using directed acyclic graphs. This allows for theoretical justification of appropriate confounder adjustment and provides a framework for extending our results to more complex scenarios than those examined in this paper. We also discuss several interpretational issues relating to unexplained residual models within a causal framework. We argue that unexplained residual models offer no additional insights compared to traditional regression methods, and, in fact, are more challenging to implement; moreover, they artificially reduce estimated standard errors. Consequently, we conclude that unexplained residual models, if used, must be implemented with great care.

Identifiants

pubmed: 29451093
doi: 10.1177/0962280218756158
pmc: PMC6484949
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1347-1364

Subventions

Organisme : Medical Research Council
ID : MR/S037578/1
Pays : United Kingdom

Références

J Epidemiol Community Health. 2012 Feb;66(2):149-54
pubmed: 21325148
Am J Hum Biol. 2015 Jan-Feb;27(1):69-83
pubmed: 25070272
Hypertension. 2016 Nov;68(5):1123-1131
pubmed: 27672027
J Pediatr. 2017 Jan;180:53-61.e3
pubmed: 27823768
Am J Epidemiol. 2006 Jan 1;163(1):84-96
pubmed: 16306313
J Hypertens. 2011 Oct;29(10):1871-9
pubmed: 21881523
Heart. 2016 Sep 1;102(17):1380-7
pubmed: 27056972
J Pediatr. 2014 Dec;165(6):1109-1115.e3
pubmed: 25262301
BMC Med Res Methodol. 2016 Apr 08;16:41
pubmed: 27059178
J Clin Epidemiol. 2007 Mar;60(3):318-9; author reply 319-20
pubmed: 17292027
Int J Obes (Lond). 2015 Apr;39(4):586-92
pubmed: 25435256
Int J Obes (Lond). 2016 Jul;40(7):1070-8
pubmed: 27143034
Int J Obes (Lond). 2016 Jan;40(1):14-21
pubmed: 26395747
J Hypertens. 2016 Jul;34(7):1396-406
pubmed: 27115338
Int J Epidemiol. 2009 Jun;38(3):724-32
pubmed: 19376883
Lancet. 2013 Aug 10;382(9891):525-34
pubmed: 23541370
J Hum Hypertens. 2006 Sep;20(9):646-57
pubmed: 16691183
Epidemiology. 2011 Sep;22(5):745
pubmed: 21811114
BMJ. 2000 Apr 8;320(7240):967-71
pubmed: 10753147
Respirology. 2016 May;21(4):674-82
pubmed: 26699232
PLoS One. 2013;8(2):e56078
pubmed: 23405253
Dev Med Child Neurol. 2010 Jan;52(1):40-6
pubmed: 19758366
Stroke. 2007 Feb;38(2):264-70
pubmed: 17218608
Acta Paediatr. 2011 Aug;100(8):1113-8
pubmed: 21366692
Arch Pediatr Adolesc Med. 1996 Nov;150(11):1122-9
pubmed: 8904851
Int J Epidemiol. 2016 Aug;45(4):1091-1102
pubmed: 27413103
J Clin Epidemiol. 2005 Dec;58(12):1320-4
pubmed: 16291478
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894
pubmed: 28089956
Am J Epidemiol. 2011 Nov 1;174(9):1028-35
pubmed: 21940799
Int J Epidemiol. 2009 Oct;38(5):1401-10
pubmed: 19661279
Int J Epidemiol. 2013 Oct;42(5):1327-39
pubmed: 24038715
Am J Epidemiol. 2005 Jan 1;161(1):27-32
pubmed: 15615910
Am J Clin Nutr. 2015 Sep;102(3):593-9
pubmed: 26224296
Am J Clin Nutr. 2009 May;89(5):1383-92
pubmed: 19297457
Am J Clin Nutr. 2014 Jul;100(1):182-8
pubmed: 24808488
J Nutr. 2010 Feb;140(2):348-54
pubmed: 20007336
Epidemiology. 2006 Jul;17(4):360-72
pubmed: 16755261
Int J Epidemiol. 2012 Jun;41(3):621-6
pubmed: 21224276
Diabetes Care. 2012 Jan;35(1):72-9
pubmed: 22100968
Int J Obes (Lond). 2010 Jan;34(1):195-202
pubmed: 19786970
Am J Epidemiol. 2016 Nov 1;184(9):605-615
pubmed: 27756719
J Pediatr. 2013 Dec;163(6):1740-1746.e4
pubmed: 24064150

Auteurs

K F Arnold (KF)

1 Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
2 School of Medicine, University of Leeds, Leeds, UK.

Gth Ellison (G)

1 Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
2 School of Medicine, University of Leeds, Leeds, UK.

S C Gadd (SC)

2 School of Medicine, University of Leeds, Leeds, UK.

J Textor (J)

3 Tumor Immunology Lab, Radboud University Medical Centre, Nijmegen, The Netherlands.

Pwg Tennant (P)

1 Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
4 School of Healthcare, University of Leeds, Leeds, UK.

A Heppenstall (A)

1 Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
5 School of Geography, University of Leeds, Leeds, UK.

M S Gilthorpe (MS)

1 Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
2 School of Medicine, University of Leeds, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH